| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.09 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |